Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.
Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA.
Cancer Causes Control. 2021 Mar;32(3):299-309. doi: 10.1007/s10552-020-01384-z. Epub 2021 Jan 18.
Among healthy postmenopausal women, levels of CA125 and CA15.3 are influenced by demographic and reproductive factors, including race/ethnicity. In this study, we sought to examine the interaction between race/ethnicity and other correlates of these biomarkers and whether the racial differences observed are simply determined by other correlates with racial differences.
In archived sera from 946 postmenopausal women who participated in the 2001-2002 cycle of the National Health and Nutrition Examination Survey, we measured CA125 and CA15.3 and examined their associations with health survey and examination data available in this cohort. We used multivariable linear regression to examine the association between CA125 and CA15.3 and race/ethnicity. We then calculated geometric means of these markers by demographic and reproductive factors stratified by race/ethnicity and used likelihood ratio tests to evaluate heterogeneity.
Non-white race was associated with lower CA125, with Non-Hispanic Black women being associated with - 29.0% (95% CI - 42.5%, - 12.2%) difference and Mexican American women being associated with - 6.4% (95% CI - 18.1%, 6.9%) difference on average compared to Non-Hispanic White women. Associations between CA125 and age and parity varied by race/ethnicity. Non-Hispanic Black women were associated with higher CA15.3 compared to Non-Hispanic White women, with 17.3% (95% CI - 0.5%, 38.3%) differences on average. Associations between CA15.3 and age, number of births, and age at natural menopause varied by race/ethnicity.
Among postmenopausal women, Non-Hispanic Black women were associated with lower CA125 and higher CA15.3 levels compared to Non-Hispanic White women. Our results support that race/ethnicity should be considered when assigning thresholds for these biomarkers being tested for diagnostic or screening purposes.
在健康绝经后女性中,CA125 和 CA15.3 水平受人口统计学和生殖因素的影响,包括种族/民族。本研究旨在探讨种族/民族与这些生物标志物其他相关因素之间的相互作用,以及观察到的种族差异是否仅仅由具有种族差异的其他相关因素决定。
在参加 2001-2002 年全国健康与营养调查周期的 946 名绝经后女性的存档血清中,我们测量了 CA125 和 CA15.3,并检查了它们与该队列中可用的健康调查和检查数据的关联。我们使用多变量线性回归来检查 CA125 和 CA15.3 与种族/民族之间的关联。然后,我们根据种族/民族对这些标志物的几何平均值进行分层,并使用似然比检验来评估异质性。
非白种人种族与较低的 CA125 相关,与非西班牙裔黑人女性相比,平均差异为 -29.0%(95%CI -42.5%,-12.2%),与墨西哥裔美国女性相比,平均差异为 -6.4%(95%CI -18.1%,6.9%)。CA125 与年龄和产次之间的关联因种族/民族而异。与非西班牙裔白人女性相比,非西班牙裔黑人女性的 CA15.3 水平较高,平均差异为 17.3%(95%CI -0.5%,38.3%)。CA15.3 与年龄、生育次数和自然绝经年龄之间的关联因种族/民族而异。
在绝经后女性中,与非西班牙裔白人女性相比,非西班牙裔黑人女性的 CA125 水平较低,CA15.3 水平较高。我们的研究结果支持在为诊断或筛查目的测试这些生物标志物时应考虑种族/民族。